000281635 001__ 281635
000281635 005__ 20251103102758.0
000281635 0247_ $$2doi$$a10.1186/s12883-025-04440-w
000281635 0247_ $$2pmid$$apmid:41057832
000281635 037__ $$aDZNE-2025-01158
000281635 041__ $$aEnglish
000281635 082__ $$a610
000281635 1001_ $$00000-0002-7980-484X$$aHeyne, Svenja$$b0
000281635 245__ $$aHow can we reduce psychological burden for patients of amyotrophic lateral sclerosis and their family caregivers? - Insights from the participatory multi-method study 'potentiALS'.
000281635 260__ $$aLondon$$bBioMed Central$$c2025
000281635 3367_ $$2DRIVER$$aarticle
000281635 3367_ $$2DataCite$$aOutput Types/Journal article
000281635 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1762161403_20023
000281635 3367_ $$2BibTeX$$aARTICLE
000281635 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000281635 3367_ $$00$$2EndNote$$aJournal Article
000281635 520__ $$aAmyotrophic lateral sclerosis (ALS) is a progressive, fatal motor neuron disease that severely impacts patients' physical and emotional well-being, while also imposing significant burdens on family caregivers. Despite the high psychosocial demands as part of the multidimensional burden, evidence for effective interventions remains limited. This study employed a participatory approach to assess the support needs of ALS patients and caregivers and to evaluate their preferences for psychosocial therapies to derive a therapeutic framework.In this observational multi-method study, ALS patients, their family caregivers, and healthcare professionals (HCPs) were actively involved throughout the research process. Quantitative Data were collected through structured questionnaires assessing quality of life (e.g., MQoL, SEIQoL-Q), depression and anxiety (ADI-12, HADS), and caregiver burden (BSFC-s). Feedback was obtained through structured group sessions that combined brief introductions, practical exercises, and subsequent evaluations of four therapy approaches - cognitive behavioral therapy (CBT), psychodynamic therapy (PT), acceptance and commitment therapy (ACT), and meaning-centered therapy (MCT).14 patients, 17 caregivers and nine HCPs participated in the study. Among patients, ACT was the most frequently selected (37.5%), followed by CBT (31.3%), MCT (18.8%), and PT (12.5%) with similar distribution in caregiver attendance. Across all therapy approaches, both patients and caregivers rated the beneficial aspects highly (mean scores of 4.18, and 4.12, respectively, on a scale from 1 to 5) and identified relatively few limitations (mean scores of 2.18 and 2.09, respectively, on a scale from 1 to 5). HCPs corroborated these findings, noting that while the therapies were effective in offering emotional support and facilitating open dialogue, challenges such as time constraints and adapting interventions for speech limitations remain. Notably, caregivers showed a strong preference for individualized therapy, while patients favored a mix of individual and group formats.Our study highlights the distinct yet interconnected psychosocial needs of ALS patients and their caregivers. Tailored interventions should blend emotional support, open dialogue, and a structured therapeutic framework, while also emphasizing the need for adaptable delivery models in clinical practice. These findings support the development of scalable, patient-centered psychosocial support approaches as part of the multidimensional care in ALS.The trial is registered at ClinicalTrials.gov (number: NCT06441448, registration date: May 28, 2024).
000281635 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000281635 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000281635 650_7 $$2Other$$aAmyotrophic lateral sclerosis
000281635 650_7 $$2Other$$aFamily caregivers
000281635 650_7 $$2Other$$aParticipatory approach
000281635 650_7 $$2Other$$aPsychotherapy
000281635 650_7 $$2Other$$aSupportive care
000281635 650_2 $$2MeSH$$aHumans
000281635 650_2 $$2MeSH$$aAmyotrophic Lateral Sclerosis: psychology
000281635 650_2 $$2MeSH$$aAmyotrophic Lateral Sclerosis: therapy
000281635 650_2 $$2MeSH$$aMale
000281635 650_2 $$2MeSH$$aCaregivers: psychology
000281635 650_2 $$2MeSH$$aFemale
000281635 650_2 $$2MeSH$$aMiddle Aged
000281635 650_2 $$2MeSH$$aAged
000281635 650_2 $$2MeSH$$aQuality of Life: psychology
000281635 650_2 $$2MeSH$$aAdult
000281635 650_2 $$2MeSH$$aCost of Illness
000281635 650_2 $$2MeSH$$aSurveys and Questionnaires
000281635 650_2 $$2MeSH$$aCognitive Behavioral Therapy: methods
000281635 7001_ $$aKuzmanova, Adelina$$b1
000281635 7001_ $$aEsser, Peter$$b2
000281635 7001_ $$0P:(DE-2719)2812121$$aLinse, Katharina$$b3$$udzne
000281635 7001_ $$0P:(DE-2719)2811849$$aGünther, René$$b4$$udzne
000281635 7001_ $$aMehnert-Theuerkauf, Anja$$b5
000281635 7001_ $$aMetelmann, Moritz$$b6
000281635 773__ $$0PERI:(DE-600)2041347-6$$a10.1186/s12883-025-04440-w$$gVol. 25, no. 1, p. 414$$n1$$p414$$tBMC neurology$$v25$$x1471-2377$$y2025
000281635 8564_ $$uhttps://pub.dzne.de/record/281635/files/DZNE-2025-01158%20SUP1.docx
000281635 8564_ $$uhttps://pub.dzne.de/record/281635/files/DZNE-2025-01158%20SUP2.docx
000281635 8564_ $$uhttps://pub.dzne.de/record/281635/files/DZNE-2025-01158.pdf$$yOpenAccess
000281635 8564_ $$uhttps://pub.dzne.de/record/281635/files/DZNE-2025-01158%20SUP1.doc
000281635 8564_ $$uhttps://pub.dzne.de/record/281635/files/DZNE-2025-01158%20SUP1.odt
000281635 8564_ $$uhttps://pub.dzne.de/record/281635/files/DZNE-2025-01158%20SUP1.pdf
000281635 8564_ $$uhttps://pub.dzne.de/record/281635/files/DZNE-2025-01158%20SUP2.doc
000281635 8564_ $$uhttps://pub.dzne.de/record/281635/files/DZNE-2025-01158%20SUP2.odt
000281635 8564_ $$uhttps://pub.dzne.de/record/281635/files/DZNE-2025-01158%20SUP2.pdf
000281635 8564_ $$uhttps://pub.dzne.de/record/281635/files/DZNE-2025-01158.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000281635 909CO $$ooai:pub.dzne.de:281635$$popenaire$$popen_access$$pVDB$$pdriver$$pdnbdelivery
000281635 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)2812121$$aExternal Institute$$b3$$kExtern
000281635 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811849$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b4$$kDZNE
000281635 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000281635 9141_ $$y2025
000281635 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-27
000281635 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-27
000281635 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000281635 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-27
000281635 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBMC NEUROL : 2022$$d2024-12-27
000281635 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-04-10T15:34:49Z
000281635 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-04-10T15:34:49Z
000281635 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-27
000281635 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-27
000281635 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-27
000281635 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-27
000281635 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000281635 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-27
000281635 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-27
000281635 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-27
000281635 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-27
000281635 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-27
000281635 9201_ $$0I:(DE-2719)1710012$$kAG Falkenburger$$lTranslational Parkinson Research$$x0
000281635 980__ $$ajournal
000281635 980__ $$aVDB
000281635 980__ $$aUNRESTRICTED
000281635 980__ $$aI:(DE-2719)1710012
000281635 9801_ $$aFullTexts